Cargando…
Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
Autores principales: | Karmouty-Quintana, Harry, Guignabert, Christophe, Kwapiszewska, Grazyna, Ormiston, Mark L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298242/ https://www.ncbi.nlm.nih.gov/pubmed/30618793 http://dx.doi.org/10.3389/fphys.2018.01777 |
Ejemplares similares
-
Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension
por: Sharifi Kia, Danial, et al.
Publicado: (2021) -
Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018) -
Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension
por: Mertens, Tinne C. J., et al.
Publicado: (2018) -
Hypertrophy of the right ventricle by pulmonary artery banding in rats: a study of structural, functional, and transcriptomics alterations in the right and left ventricles
por: Silva, Jairo Montemor Augusto, et al.
Publicado: (2023) -
An integrated proteomic and transcriptomic signature of the failing right ventricle in monocrotaline induced pulmonary arterial hypertension in male rats
por: Hindmarch, Charles Colin Thomas, et al.
Publicado: (2022)